Immunohematology Market Growth Forecast: Exploring Trends and Opportunities for the Next Decade
Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!
How has the immunohematology market grown over the years?
The size of the immunohematology market has consistently inflated over the past years. With an assertion to expand from $2.46 billion in 2024 to $2.57 billion in 2025, it’s anticipated to mature at a compound annual growth rate (CAGR) of 4.6%. The historic period growth is influenced by progression in blood transfusion science, escalating instances of blood disorders, proliferation of blood banks, government strata directing towards blood safety, a rise in surgical procedures along with enhanced cognizance about risks linked to transfusion.
What Is the forecasted market size and growth rate for the immunohematology market?
Anticipated strong expansion is on the horizon for the immunohematology market size in the forthcoming years. It is slated to soar to “$3.24 billion by 2029, boasting a compound annual growth rate (CAGR) of 5.9%. This predicted boosting during the projected period can be contributed to factors like the rising need for point-of-care testing, the emergence of innovative blood-oriented products, broadening healthcare infrastructure, genetic examinations for blood compatibility, and the backing of regulations for blood safety. During the forecast period, key tendencies are likely to be automation, high-throughput systems, molecular methods of blood typing, techniques for antibody identification, patient blood management schemes, the incorporation of artificial intelligence in assessments, and the integration of telemedicine.
Get your immunohematology market report here!
https://www.thebusinessresearchcompany.com/report/immunohematology-global-market-report
What are the major factors driving growth in the immunohematology market?
An increase in the rate of hematological disorders is anticipated to fuel advancement in the immunohematology market. Hematological disorders, which are a varied set of conditions impacting the blood and blood constituents like red and white blood cells, platelets, and plasma, are on the rise. Immunohematology plays a crucial role in ensuring the safety and efficacy of blood transfusions by averting transfusion reactions triggered by incompatible blood groups or antibodies in the recipient’s blood. Techniques in immunohematology are also employed to detect and remedy diseases associated with the immune system that may have implications on the hematological system. As an example, Cancer Research UK, a research institution based in the UK, projects that the number of new leukemia cases due to hematological disorders in the UK is likely to escalate from an estimated 12,400 cases in 2023-2025 to about 14,500 cases in 2038-2040. The increasing incidence rate of hematological disorders, therefore, is prompting the expansion of the immunohematology market.
What key areas define the segmentation of the global immunohematology Market?
The immunohematology market covered in this report is segmented –
1) By Product: Analyzers And Systems, Reagents
2) By Technology: Biochips, Erythrocyte-Magnetized Technology (Met), Gel Cards, Microplates, Polymerase Chain Reaction (PCR)
3) By Disease: Blood-Related Diseases, HIV, Hepatitis
4) By Application: Pretransfusion Testing, Investigation Of Immune Hemolysis, Perinatal Testing, Blood Group Phenotyping, Leucocyte And Platelet Serology
5) By End User: Blood Banks, Diagnostic And Reference Laboratories, Hospitals, Academic And Research Institutes
Subsegments:
1) By Analyzers And Systems: Blood Typing Analyzers, Cross-Matching Analyzers, Gel Card Systems
2) By Reagents: Blood Grouping Reagents, Antisera, Control Serum
Get your free sample now – explore exclusive market insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=10295&type=smp
What are the top market players propelling the growth of the immunohematology industry?
Major companies operating in the immunohematology market include Ortho Clinical Diagnostics Inc., Immunocor Inc., Abbott Laboratories, Siemens Healthineers AG, Grifols S.A., Beckman Coulter Inc., Thermo Fisher Scientific Inc., Becton Dickinson and Company, Merck Co. & KGaA, Bio-Rad Laboratories, Sysmex Corporation, Danaher Corporation, Biosystems S.A., Roche Holdings AG, Mindray Medical International Limited, F.Hoffmann La-Roche Ltd., Biotest AG, Cardinal Health Inc., Quotient Limited, DiaSorin S.p.A., Lorne Laboratories Ltd., Biokit S.A., Avox Technologies, Diagnostic Automation/Cortez Diagnostics Inc., Inno-train Diagnostik GmbH, Drucker Diagnostics Inc., Immundia Diagnostics Pvt. Ltd.
What are the key trends shaping the future of the immunohematology market?
Leading firms in the immunohematology market are strategizing to create unique diagnostic tools, such as soluble recombinant proteins, to counter the interference from the cancer treatment daratumumab. Soluble recombinant protein, generated with the help of recombinant DNA technology, retains its proper structure and function in a host cell or solution, making it valuable for research and therapeutic uses. For example, Grifols, S.A., a pharmaceutical company based in Spain, introduced the Grifols sCD38 solution in November 2023. This represents the first-ever soluble recombinant protein, designed to combat the interruption caused by cancer therapy daratumumab in essential blood transfusion compatibility checks. Aimed specifically at multiple myeloma patients, this pioneering solution prevents daratumumab from binding to CD38 proteins on red blood cells, thereby guaranteeing accurate pre-transfusion test results. By simplifying the procedure for screening, identifying, and cross-matching, Grifols sCD38 improves blood transfusion procedures and reduces the delay in providing critical transfusions.
Unlock exclusive market insights – purchase your research report now for a swift delivery!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=10295
What regions are dominating the immunohematology market growth?
North America was the largest region in the immunohematology market in 2024. Asia-Pacific is expected to be the fastest-growing region in the global immunohematology market during the forecast period. The regions covered in the immunohematology market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Browse Through More Similar Reports By The Business Research Company:
Out-of-Home Advertising Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/out-of-home-advertising-global-market-report
Advertising Agencies Global Market Opportunities And Strategies To 2031: COVID-19 Impact And Recovery
https://www.thebusinessresearchcompany.com/report/advertising-agencies-market
Print Advertising Distribution Global Market Report 2024
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
